Related Experiment Videos
Congenital chylothorax treated with octreotide
1Department of Pediatrics, SSK Region Hospital and Medical Faculty of Gaziantep University, Turkey. pediatristsahin@mynet.com
Indian Journal of Pediatrics
|November 8, 2005
Summary
Octreotide, a somatostatin analogue, offers a potential non-surgical treatment for congenital chylothorax. This case study shows successful avoidance of surgery in an infant unresponsive to conservative management.
Area of Science:
- Neonatal Medicine
- Pediatric Surgery
- Pharmacology
Background:
- Congenital chylothorax involves lymphatic fluid accumulation in the pleural space, often requiring surgery.
- Existing treatments for refractory congenital chylothorax are limited.
Observation:
- A 33-week gestation infant presented with large bilateral pleural effusions.
- The infant did not respond to conservative management for congenital chylothorax.
Findings:
- A compassionate trial of octreotide (somatostatin analogue) infusion was initiated.
- Octreotide treatment led to prompt respiratory improvement and cessation of pleural drainage.
- Surgery was successfully avoided in this case.
Implications:
- Octreotide may be a viable alternative to surgery for congenital chylothorax.
- Further research is needed to confirm octreotide's efficacy in congenital chylothorax.
- This case highlights a potential new therapeutic avenue for a challenging neonatal condition.